Epitheliotropic cutaneous lymphoma (mycosis fungoides) in a dog by Bhang, Dong Ha et al.
JOURNAL OF
Veterinary 
Science
J. Vet. Sci. (2006), 7(1), 97–99
Epitheliotropic cutaneous lymphoma (mycosis fungoides) in a dog
Dong Ha Bhang
1, Ul Soo Choi
3, Min Kyu Kim
1, Eun-Hwa Choi
1, Min-Soo kang
2, Cheol-Yong Hwang
1,
Dae-Yong Kim
2, Hwa Young Youn
1,*, Chang Woo Lee
3
1Departments of Veterinary Internal Medicine, 
2Veterinary Pathology, and 
3Veterinary Clinical Pathology, College of Veterinary 
Medicine, Seoul National University, Seoul 151-742, Korea
A seven-year-old castrated male Yorkshire terrier dog
was presented for a recurrent skin disease. Erythematous
skin during the first visit progressed from multiple
plaques to patch lesions and exudative erosion in the oral
mucosa membrane. Biopsy samples were taken from
erythematous skin and were diagnosed with epitheliotropic
T cell cutaneous lymphoma by histopathology and
immunochemical stain. In serum chemistry, the dog had a
hypercalcemia (15.7 mg/dl) and mild increased alkaline
phosphatase (417 U/l). Immunohistochemistry was performed
to detect parathyroid hormone-related peptide (PTH-rP) in
epitheliotropic cutaneous lymphoma tissues but the neoplastic
cells were not labeled with anti-PTH-rP antibodies. The
patient was treated with prednisolone and isotretinoin.
However, the dog died unexpectedly.
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Malignant lymphoma accounts for 7~24% of all canine
neoplasia [6]. Canine epitheliotropic T-cell lymphoma
represents only 3~8% of all canine lymphomas [2,8]. It can
be subdivided into non-epitheliotropic and epitheliotropic
forms [4]. Epitheliotropic cutaneous lymphoma is usually of
T cell origin and encompasses a spectrum of disease,
including mycosis fungides, Sezary syndrome, and pagetoid
reticulosis [5,10,11]. It occurs in old dogs (average age of 9
to 11 years) and has no breed and sex predilection [1]. Four
clinical presentations of the disease have been described.
Histopathologically, mycosis fungoides is characterized
mycosis cells [10]. The objective of this report is to appreciate
the clinical course, diagnosis, treatment, and prognosis of
epitheliotropic cutaneous lymphoma in a dog which has
rarely been reported in Korea.
Case history and clinical findings: A seven-year-old
castrated male Yorkshire terrier dog had a 6 year history of
recurrent skin problems such as pruritus, excessive scales,
and generalized erythema. Initial physical examination
revealed an excess of scales, mild generalized erythema, and
no palpable superficial lymph node. There was no evidence
of skin infection in basic dermatologic examinations.
Allergic dermatitis was suspected on the basis of these
history and clinical signs. The dog was initially treated with
oral prednisolone (0.25 mg/kg, BID), pentoxifylline (10 mg/
kg, BID), and clemastine (0.05 mg/kg, BID). However, the
dog did not show clinical improvement. Examination one
month later showed a generalized distribution of raised
plaques with overlying scales (Fig. 1), ulceration, depig-
mentation, erythema and tissue proliferation in the oral
mucosal membrane, periocular area with exudates and
crusts (Fig. 2).
Clinical pathology: Smears of the oral mucous membranes
and skin plaques aspirates were stained with aqueous Wright
stain (Diff-Quik; International Reagents, Japan). The smears
were moderately cellular and the dominant population
consisted of medium sized lymphocytes with some
macrophages. The lymphocytes had mild to moderate
amounts of pale to weakly basophilic cytoplasms with
eccentric nuclei or plasmacytic differentiation. Nuclei had
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Fig. 1. Generalized distribution of raised plaque overlying scale
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fine and smooth chromatin and contained no visible nucleoli.
(Fig. 3). These findings strongly suggested cutaneous
lymphoma. Other differential diagnoses included histiocytoma,
chronic inflammation, and plamsmacytomas.
A complete blood count, serum chemistry panel, and
analysis of urine collected by cystocentesis were carried out.
Hyepercalcemia (15.6 mg/dl) and increased alkaline
phosphatase (417 U/l) were revealed in serum chemistry.
Other abnormalities were not presented. Serum parathyroid
hormone-related peptide (PTHrP) and parathyroid hormone
(PTH) concentration could not be measured.
Biopsies were taken from the plaque of abdomen and
trunk, fixed with 10% phospate-buffered formalin, routinely
processed, and stained with hematoxylin and eosin for light
microscopic examination. Histologically, diffuse infiltrations
of neoplastic lymphoid cells were noted in the intraepidermis
and associated follicular epithelium (Fig. 4). The neoplastic
cells were round and had distinct cell borders, hyperchromatic
nuclei, and moderate amounts of eosinophilic cytoplasm were
surrounded by clear space. The mitotic rate was low,
averaging 1~2/hpf. Sparse to mild infiltration of neoplastic
cells were also noted in the superficial dermis. Immuno-
histochemical studies were performed on paraffinembedded
sections with antibodies to specific T-cell maker CD3, the
B-cell and plasma cell maker CD79a, E-cadherin, and
pancytokeratin using routine avidin-biotin complex methods
[3]. The intraepithelial neoplastic cells were strongly
positive for CD3 but were negative for CD79a, E-cadherin,
and pancytokeratin, thus demonstrating that this tumor was
of the T-lymphoid lineage in origin (Fig. 5).
Immunohistochemistry was performed to detect PTHrP
(rabbit polyclonal, 1 : 100; Oncogene, USA) by the avidin-
biotin-peroxidase complex method for neoplastic tissue,
while normal skin was a positive control. However, neoplastic
cells were negative for PTHrP.
Treatment: The dog was started on prednisolone (2 mg/
Fig. 2. Hyperemia, tissue proliferation, erosion, and ulcer in the
oral mucosal membrane with crusts and exudates.
Fig. 3. Aspirate smear of the plaque. Predominant cells are
medium to large lymphocytes with varying amounts of weakly
basophilic cytoplasm resembling histiocytes. Chromatin is fine
and nucleoli are indistinct. Wright stain, ×40.
Fig. 4. Note intraepidermal and follicular infiltration of lymphoi d
cells (arrow). H&E stain, ×120.
Fig. 5. Intraepidermis tumor, Note strong positive tumor cells fo r
CD3. Avdin-biotin-peroxidase complex method, Mayer’s
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kg, PO, BID) and isotretinoin (3 mg/kg/day, PO) [4,12].
After two weeks of therapy, the skin lesions were markedly
improved. The serum calcium level was declined to 9.2 mg/
dl. However the dog died unexpectedely. Permission for
necropsy was denied by the owner.
Four stages have been used to describe the clinical
appearance and course of mycosis fungoides: 1.generalized
pruritic erythema and scaling (exfoliative erythroderma); 2.
mucocutaneous erythema, infiltration, depigmentation, and
ulceration; 3. solitary or multiple cutaneous plaque or
nodules; 4. infiltrative and ulcerative oral mucosal disease
[10]. The exofoliative erythroderma stage is usually mis-
diagnosed as allergy, scabies, or seborrhea [7]. In stage 3 to
4, clinical features of the disease is usually misdiagnosed as
an immune-mediated skin disease (pemphigus vulgaris,
bullous pemphigoid, or lupus erythematosus) or non neoplastic,
chronic stomatitis. Initially, this patient, whose clinical signs
were not controlled by glucocorticoid therapy, was also
misdiagnosed with atopic dermatitis. As the disease progressed,
a generalized distribution of slightly raised serpiginous or
annular plaques with scales, mucocutaneous ulceration,
erythema with exudates and crusts developed and the patient
was finally diagnosed epitheliotropic T-cell cutaneous
lymphoma. Mycosis fungoides may be similar to clinical
signs or lesions of so many others diseases like atopic
dermatitis, scabies, and pemphigus; therefore, clinicians
should consider mycosis fungoides as a differential diagnosis.
Although it is probably unnecessary to include mycosis
fungoides in the differential diagnosis of the classic forms of
these diseases, it should be suspected in patients that fail to
respond to appropriate therapy for a more common
condition [2,7].
Hypercalcemia is one of the most common paraneoplastic
syndromes in dogs with lymphoma, occurring in approximately
10% to 40% of the clinical cases [8]. In dogs with lymphoma,
20% have elevated PTH-rP concentration [8] but hypercalcemia
is not a common feature of mycosis fungoides [2]. In humans,
Obagi et al. [9] reported that patients with mycosis fungoides
who had hypercalcemia exhibited strong expression of PTH-
rp in keratinocytes and abnormal lymphocytes while there
was a slight immunoreactivity for PTH-rp in keratinocytes
as well as the infiltrating lymphocytes in the skin from the
patient with mycosis fungoides without hypercalcemia.
In this case, hypercalcemia was presented. However,
plasma PTH-rP and PTH were not assayed. We performed
immunhistochemistry for neoplastic tissues using anti-PTH-
rP antibody to detect PTH-rp. In immunohistochemistry, no
immunoreactivity for PTHrP was shown in the epitheliotropic
lymphoma tissue. Normal skin as a positive control was
weakly positive for PTH-rP. Therefore, we could not
conclude the reason for hypercalcemia with the mycosis
fungoides in this case. Further investigations of hypercalcemia
associated with canine mycosis fungoides are needed.
Therapy for mycosis fungoides in dogs has usually been
of little or no benefit. Rarely, solitary nodules can be
surgically excised, with long-term remissions or cures
ensuing [10]. However recurrence is common.
The patient was treated with prednisolone and isotretinoin.
Marked remission of clinical signs was obtained three
weeks after the treatment. The patient died suddenly at night
while visiting our hospital. Thus, we hypothesize that this
treatment does not prevent extracutaneous development of
neoplastic lesions or eventual death.
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